Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study (Q33341954)

25 July 2017

title

Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study (English)

1 reference

25 July 2017

main subject

phase I clinical trial

0 references

1 reference

Pascal Thomas

1

1 reference

25 July 2017

G Robinet

2

1 reference

25 July 2017

R M Ferri-Dessens

3

1 reference

25 July 2017

H Léna

4

1 reference

25 July 2017

S Gouva

5

1 reference

25 July 2017

J M Vernejoux

6

1 reference

25 July 2017

J P Kleisbauer

7

1 reference

25 July 2017

publication date

1 May 2002

1 reference

25 July 2017

1 reference

25 July 2017

volume

36

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

191-198

1 reference

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

Studies on mutagenesis and repair induced by platinum analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900480-9

7 January 2021

10.1016/S0169-5002(01)00480-9

Identifiers

DOI

1 reference

25 July 2017

1 reference